Alnylam Pharmaceuticals shares owned by 683 Capital Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by 683 Capital Management
from 13F filings
Historical chart of 683 Capital Management investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by 683 Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $62M | 136k | 456.00 |
| 2025-06-30 | $46M | 141k | 326.09 |
| 2025-03-31 | $14M | 51k | 270.02 |
| 2024-12-31 | $14M | 59k | 235.31 |
| 2024-09-30 | $34M | 123k | 275.03 |
| 2024-06-30 | $30M | 123k | 243.00 |
| 2024-03-31 | $5.4M | 36k | 149.45 |
| 2023-09-30 | $1.8M | 10k | 177.10 |
| 2022-06-30 | $5.7M | 39k | 145.85 |
| 2022-03-31 | $8.0M | 49k | 163.29 |
| 2021-12-31 | $8.3M | 49k | 169.57 |
| 2021-09-30 | $9.3M | 49k | 188.82 |
| 2021-06-30 | $9.3M | 55k | 169.53 |
| 2021-03-31 | $7.8M | 55k | 141.18 |
| 2020-12-31 | $14M | 105k | 129.96 |
| 2020-09-30 | $15M | 105k | 145.60 |
| 2020-06-30 | $16M | 105k | 148.11 |
| 2020-03-31 | $19M | 170k | 108.85 |
| 2019-12-31 | $26M | 225k | 115.17 |
| 2019-09-30 | $29M | 354k | 80.42 |
| 2019-06-30 | $25M | 340k | 72.56 |
| 2019-03-31 | $31M | 326k | 93.45 |
| 2018-12-31 | $24M | 326k | 72.91 |
| 2018-09-30 | $26M | 300k | 87.52 |
| 2018-06-30 | $30M | 300k | 98.49 |
| 2018-03-31 | $23M | 190k | 119.10 |
| 2017-12-31 | $25M | 200k | 127.05 |
| 2017-09-30 | $28M | 240k | 117.49 |
| 2017-06-30 | $22M | 270k | 79.76 |
| 2017-03-31 | $14M | 270k | 51.25 |
| 2016-12-31 | $10M | 270k | 37.44 |
| 2016-09-30 | $8.1M | 120k | 67.78 |